Akm E. Ullah

Array ( [id] => 1392281 [patent_doc_number] => 06541251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Pancreatic progenitor 1 gene and its uses' [patent_app_type] => B1 [patent_app_number] => 09/844497 [patent_app_country] => US [patent_app_date] => 2001-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12457 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541251.pdf [firstpage_image] =>[orig_patent_app_number] => 09844497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7414196 [patent_doc_number] => 20040025197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Transgenic animal' [patent_app_type] => new [patent_app_number] => 10/258561 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15560 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20040025197.pdf [firstpage_image] =>[orig_patent_app_number] => 10258561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7095265 [patent_doc_number] => 20010034885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Non-human animal deficient in function of pituitary adenylate cyclase-activating polypeptide gene' [patent_app_type] => new [patent_app_number] => 09/835627 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2819 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034885.pdf [firstpage_image] =>[orig_patent_app_number] => 09835627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859846 [patent_doc_number] => 20020123473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'IL-12 gene expression and delivery systems and uses' [patent_app_type] => new [patent_app_number] => 09/836866 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15579 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123473.pdf [firstpage_image] =>[orig_patent_app_number] => 09836866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947892 [patent_doc_number] => 20010021526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Cellular and animal models for diseases associated with mitochondrial defects' [patent_app_type] => new [patent_app_number] => 09/825525 [patent_app_country] => US [patent_app_date] => 2001-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9856 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021526.pdf [firstpage_image] =>[orig_patent_app_number] => 09825525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395602 [patent_doc_number] => 06534062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-18 [patent_title] => 'Methods for increasing a cytotoxic T lymphocyte response in vivo' [patent_app_type] => B2 [patent_app_number] => 09/820484 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 38 [patent_no_of_words] => 23412 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534062.pdf [firstpage_image] =>[orig_patent_app_number] => 09820484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414454 [patent_doc_number] => 20020038467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/815944 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24487 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038467.pdf [firstpage_image] =>[orig_patent_app_number] => 09815944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985879 [patent_doc_number] => 20020098540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Novel polypeptides, and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/815248 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30002 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098540.pdf [firstpage_image] =>[orig_patent_app_number] => 09815248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473395 [patent_doc_number] => 20020022255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Transgenic mice containing sulfotransferase gene disruptions' [patent_app_type] => new [patent_app_number] => 09/816790 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24692 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022255.pdf [firstpage_image] =>[orig_patent_app_number] => 09816790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6649785 [patent_doc_number] => 20020088012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Transgenic mice containing lymphoid-specific GPCR gene disruptions' [patent_app_type] => new [patent_app_number] => 09/815937 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25670 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20020088012.pdf [firstpage_image] =>[orig_patent_app_number] => 09815937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1182282 [patent_doc_number] => 06737559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-18 [patent_title] => 'See-through medaka' [patent_app_type] => B2 [patent_app_number] => 09/814047 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 0 [patent_no_of_words] => 10418 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737559.pdf [firstpage_image] =>[orig_patent_app_number] => 09814047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635377 [patent_doc_number] => 20030211612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Establishment of cellular manipulations which enhance oligo-mediated gene targeting' [patent_app_type] => new [patent_app_number] => 10/239595 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22193 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211612.pdf [firstpage_image] =>[orig_patent_app_number] => 10239595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1175186 [patent_doc_number] => 06743423 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-01 [patent_title] => 'Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy- induced resistance in cancer patients' [patent_app_type] => B1 [patent_app_number] => 09/719336 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3376 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743423.pdf [firstpage_image] =>[orig_patent_app_number] => 09719336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414450 [patent_doc_number] => 20020038466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Transgenic mice containing magnesium dependent protein phosphatase gene disruptions' [patent_app_type] => new [patent_app_number] => 09/815935 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24842 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038466.pdf [firstpage_image] =>[orig_patent_app_number] => 09815935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1272207 [patent_doc_number] => 06649159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-18 [patent_title] => 'Whole-body optical imaging of gene expression and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/812710 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12803 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649159.pdf [firstpage_image] =>[orig_patent_app_number] => 09812710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406088 [patent_doc_number] => 20040040046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'TRANSGENIC MICE CONTAINING RETINA-SPECIFIC NUCLEAR RECEPTOR GENE DISRUPTIONS' [patent_app_type] => new [patent_app_number] => 09/811361 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24830 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20040040046.pdf [firstpage_image] =>[orig_patent_app_number] => 09811361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908139 [patent_doc_number] => 20020143000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment' [patent_app_type] => new [patent_app_number] => 09/801925 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5208 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20020143000.pdf [firstpage_image] =>[orig_patent_app_number] => 09801925 [rel_patent_id] =>[rel_patent_doc_number] =>)